UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act Of 1934
 
Date of Report (Date of earliest event reported): April 28, 2022
 
 
ATI PHYSICAL THERAPY, INC.
 
(Exact name of registrant as specified in its charter)
 

Delaware 001-39439
 85-1408039
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

790 Remington Boulevard
 
 
 
 
 
Bolingbrook, Illinois
60440
(Address of principal executive offices)
(Zip Code)
 
(630) 296-2223
(Registrant’s telephone number, including area code)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class
 
Trading
Symbol
 
Name of Each Exchange
on Which Registered
         
Class A Common Stock, $0.0001 par value
 
 ATIP
 
New York Stock Exchange
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
 
ATIP WS
 
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 28, 2022, ATI Physical Therapy, Inc. ("ATI" or the "Company") announced the appointment of Sharon Vitti as its Chief Executive Officer.  Ms. Vitti also has been appointed to the Company’s Board of Directors as a class II member effective April 28, 2022.  Ms. Vitti will not receive any additional compensation in connection with her appointment.

There are no arrangements or understandings between Ms. Vitti and any other persons pursuant to which she was elected as a director. There are no transactions and no proposed transactions between Ms. Vitti and the Company that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Item 9.01
Financial Statements and Exhibits.

Exhibit
Number
Description
   
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: April 29, 2022 ATI Physical Therapy, Inc.
 
 
 
 
 By: /s/ Joseph Jordan
 
 Name:
Joseph Jordan
 
 Title:
Chief Financial Officer


ATI Physical Therapy (NYSE:ATIP)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more ATI Physical Therapy Charts.
ATI Physical Therapy (NYSE:ATIP)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more ATI Physical Therapy Charts.